300 related articles for article (PubMed ID: 18953185)
1. Decreased vitreal hyaluronan levels with aging.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
[TBL] [Abstract][Full Text] [Related]
2. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
3. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
4. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
5. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
Yoneda S; Hara H; Hirata A; Fukushima M; Inomata Y; Tanihara H
Jpn J Ophthalmol; 2005; 49(2):106-8. PubMed ID: 15838725
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
7. Vitreous collagen metabolism before and after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):994-8. PubMed ID: 15900480
[TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin levels in the vitreous correlate with change in visual acuity after vitrectomy.
Van Aken E; De Letter EA; Veckeneer M; Derycke L; van Enschot T; Geers I; Delanghe S; Delanghe JR
Br J Ophthalmol; 2009 Nov; 93(11):1539-45. PubMed ID: 19692381
[TBL] [Abstract][Full Text] [Related]
10. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
Shimada H; Akaza E; Yuzawa M; Kawashima M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
Er H; Doğanay S; Ozerol E; Yürekli M
Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
[TBL] [Abstract][Full Text] [Related]
12. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
[TBL] [Abstract][Full Text] [Related]
13. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
Funatsu H; Yamashita H; Noma H; Mimura T; Sakata K; Hori S
Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of fluid-air exchange during pars plana vitrectomy.
Rubin JS; Thompson JT; Sjaarda RN; Pappas SS; Glaser BM
Retina; 1995; 15(4):291-4. PubMed ID: 8545573
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
16. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
17. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S
Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of air tamponade in prevention of early recurrence of vitreal hemorrhage in diabetic patients with vitrectomy].
Brănişteanu D; Danielescu C; Irimia A; Robu M
Oftalmologia; 2006; 50(2):62-7. PubMed ID: 16927761
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
